FdaApplication
NDA 217006
Identifiers
- fda_app_no: NDA217006
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
| approval_date | 2023-04-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABILIFY ASIMTUFII | ARIPIPRAZOLE | 960MG/3.2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ABILIFY ASIMTUFII | ARIPIPRAZOLE | 720MG/2.4ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
2 products